Video

SWIFT PRIME Shows Strong Results for Endovascular Therapy Part 2

Author(s):

The results of the SWIFT PRIME Trial as well as several others have given hope that endovascular therapy could become a key tool to help treat patients who have suffered a severe stroke.

The results of the SWIFT PRIME Trial as well as several others have given hope that endovascular therapy could become a key tool to help treat patients who have suffered a severe stroke.

Jeffrey Saver, MD, FAHA, FAAN, from the Geffen School of Medicine at UCLA discussed the results of the study and the impact of the development of the therapy on the treatment of stroke at the International Stroke Conference in Nashville.

Related Videos
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
Nathan D. Wong, MD, PhD: Growing Role of Lp(a) in Cardiovascular Risk Assessment | Image Credit: UC Irvine
Laurence Sperling, MD: Expanding Cardiologists' Role in Obesity Management  | Image Credit: Emory University
Laurence Sperling, MD: Multidisciplinary Strategies to Combat Obesity Epidemic | Image Credit: Emory University
Schafer Boeder, MD: Role of SGLT2 Inhibitors and GLP-1s in Type 1 Diabetes | Image Credit: UC San Diego
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Alice Cheng, MD: Exploring the Link Between Diabetes and Dementia | Image Credit: LinkedIn
© 2024 MJH Life Sciences

All rights reserved.